Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| November 17th, 2025 |
Fostering Collaboration Across Ryan White HIV/AIDS Programs (RWHAPs) to Engage People with HIV in Care |
Health Resources and Services Administration |
| February 6th, 2029 |
Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI) |
National Institutes of Health |
| May 7th, 2029 |
Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2029 |
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) |
National Institutes of Health |
| May 25th, 2028 |
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) |
National Institutes of Health |
| February 8th, 2027 |
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 1st, 2026 |
Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 20th, 2026 |
Extension of the World Trade Center Health Registry (U50) |
Centers for Disease Control and Prevention - ERA |
| April 17th, 2029 |
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 16th, 2029 |
Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) |
National Institutes of Health |
| July 10th, 2026 |
Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 10th, 2026 |
Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 10th, 2026 |
Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 28th, 2026 |
Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed) |
National Institutes of Health |
| November 16th, 2029 |
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 20th, 2026 |
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) |
National Institutes of Health |
| July 5th, 2029 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 25th, 2029 |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) |
National Institutes of Health |
| November 10th, 2026 |
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 10th, 2026 |
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
National Institutes of Health |
|
| July 1st, 2028 |
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 29th, 2026 |
ACL National Falls Prevention Resource Center |
Administration for Community Living |
| July 22nd, 2026 |
ACL National Resource Center on Nutrition and Aging |
Administration for Community Living |
| July 29th, 2026 |
Scaling Evidence-Based Falls Prevention Programs |
Administration for Community Living |
| July 27th, 2026 |
A Demonstration to Scale Innovative Person-Centered Approaches to Falls Prevention through Clinical-Community Partnerships |
Administration for Community Living |
| November 9th, 2026 |
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) |
National Institutes of Health |
| October 2nd, 2026 |
Protecting and Improving Global Health Security by Engaging Local Partners: Strengthening and Sustaining Public Health Systems in Ghana |
Centers for Disease Control-GHC |
| January 29th, 2029 |
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) |
National Institutes of Health |
| July 9th, 2026 |
Single Source: HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Data Translation Center (U54 Clinical Trial Optional) |
National Institutes of Health |
| November 5th, 2025 |
Rural Health Transformation Program |
Centers for Medicare & Medicaid Services |
| October 9th, 2026 |
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 9th, 2026 |
HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Clinical Trial Center and Clinical Centers (U01 Clinical Trial Optional) |
National Institutes of Health |
| February 10th, 2027 |
Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) |
National Institutes of Health |
| March 9th, 2029 |
NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required) |
National Institutes of Health |
| February 8th, 2029 |
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 10th, 2026 |
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) |
National Institutes of Health |
| June 23rd, 2028 |
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 25th, 2027 |
Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) |
National Institutes of Health |
| October 9th, 2026 |
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required) |
National Institutes of Health |
| September 30th, 2026 |
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
